These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16569806)

  • 21. Risks of mifepristone abortion in context.
    Grimes DA
    Contraception; 2006 Aug; 74(2):174-5 author reply175-6. PubMed ID: 16860058
    [No Abstract]   [Full Text] [Related]  

  • 22. Risks of mifepristone abortion in context.
    Crockett SA
    Contraception; 2006 Aug; 74(2):174; author reply 175-6. PubMed ID: 16860057
    [No Abstract]   [Full Text] [Related]  

  • 23. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
    Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
    BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Updates to the US Food and Drug Administration Regulations for Mifepristone: Implications for Clinical Practice and Access to Abortion.
    Simmonds KE; Beal MW; Eagen-Torkko MK
    J Midwifery Womens Health; 2017 May; 62(3):348-352. PubMed ID: 28632953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mifepristone and misoprostol for early abortion.
    JNMA J Nepal Med Assoc; 2006; 45(161):I. PubMed ID: 17160090
    [No Abstract]   [Full Text] [Related]  

  • 26. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
    Chai J; Tang OS; Hong QQ; Chen QF; Cheng LN; Ng E; Ho PC
    Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risks of mifepristone abortion in context.
    Grimes DA
    Contraception; 2005 Mar; 71(3):161. PubMed ID: 15722063
    [No Abstract]   [Full Text] [Related]  

  • 28. Public health advisory for mifepristone.
    FDA Consum; 2005; 39(5):4-5. PubMed ID: 16421985
    [No Abstract]   [Full Text] [Related]  

  • 29. Mifepristone medical abortion in Albania: results from a pilot clinical research study.
    Bracken H; Gliozheni O; Kati K; Manoku N; Moisiu R; Shannon C; Tare V; Tasha I; Winikoff B;
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):38-46. PubMed ID: 16546815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol.
    Raghavan S; Comendant R; Digol I; Ungureanu S; Friptu V; Bracken H; Winikoff B
    Contraception; 2009 Feb; 79(2):84-90. PubMed ID: 19135563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mifepristone--a boom or a bust?
    Willke JC
    Ann Pharmacother; 2001 Mar; 35(3):376-80. PubMed ID: 11261539
    [No Abstract]   [Full Text] [Related]  

  • 32. Risks of mifepristone abortion in context.
    McGregor JA; Equiles O
    Contraception; 2005 Nov; 72(5):393; author reply 394. PubMed ID: 16246668
    [No Abstract]   [Full Text] [Related]  

  • 33. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mifepristone for termination of early pregnancy.
    FDA Consum; 2000; 34(6):7. PubMed ID: 11192820
    [No Abstract]   [Full Text] [Related]  

  • 35. In brief: Mifepristone by mail for pregnancy termination.
    Med Lett Drugs Ther; 2022 Jan; 64(1642):11. PubMed ID: 35134042
    [No Abstract]   [Full Text] [Related]  

  • 36. Review of medical abortion using mifepristone in combination with a prostaglandin analogue.
    Fiala C; Gemzel-Danielsson K
    Contraception; 2006 Jul; 74(1):66-86. PubMed ID: 16781264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early medical abortion at home.
    Massey L; Humphries M; Hague K
    J Fam Plann Reprod Health Care; 2011 Jul; 37(3):188. PubMed ID: 21697115
    [No Abstract]   [Full Text] [Related]  

  • 38. A New Label for Mifepristone.
    Greene MF; Drazen JM
    N Engl J Med; 2016 Jun; 374(23):2281-2. PubMed ID: 27276566
    [No Abstract]   [Full Text] [Related]  

  • 39. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time to Reevaluate U.S. Mifepristone Restrictions.
    Henney JE; Gayle HD
    N Engl J Med; 2019 Aug; 381(7):597-598. PubMed ID: 31242357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.